We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 66,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/3/2017 17:10 | ask him how trak and avanti are doing. He was ramping them when they were both when they were in triple digits. Meanwhile opti has gone from strength to strength with more to come. no sign of winter chill, wont see 70p again nevermind 40p and defo not 8p as the mouse predicted. i dont mind you calling me elrico, he is well respected. | incanus | |
23/3/2017 17:06 | fathenry 23 Mar '17 - 07:38 - 1036 of 1036 0 0 Edit fathenry 23 Mar '17 - 07:37 - 1035 of 1035 0 0 Edit fathenry 23 Mar '17 - 07:37 - 1034 of 1034 0 0 Edit Optibiotix (OPTI) has announced - not before time we might note- that the demerger of its 52% unit Skinbiotherapeutics and its own AIM listing is underway. I should cocoa. Book building is cracking ahead on the Skinbiotix IPO. Optibiotix currently has an adjusted 52% of Skinbiotherapeutics. SkinBiotix®, is a proprietary technology platform based on microbiome research, comprises extracts of probiotic bacteria for application to the skin. There are published proof of principle research on SkinBiotix® in models of skin shows improvement of skin barrier function, protection against Staphylococcus aureus infection and regeneration. There are three development programmes in place - cosmetic (sensitive skin), healthcare-acquired infections (HCAIs) and eczema. The business strategy is to bring programmes through proof of concept (human) trials and then seek early stage partnering; lead cosmetic application targeted to be ready for commercialisation in 2018. But Skinbiotherapeutics needs some cash to do that. Hence the IPO. As we understand it post the fund raise, Skinbiotherapeutics will be cashed up with anough dosh to take it through to commercialisation and Optibiotix will still own a loan note adjusted c44% of the equity. At some stage Optibiotix will distribute those shares to we lucky shareholders in Optibiotix and since we do not know the record date on that distribution folks would be barking mad to sell. Optibiotix thus becomes doubly exciting. Not only will it be announcing more big news soon on commercialising its products but we now have a similar process likely to happen with Skinbiotherapeutics. Game on! The shares have responded by moving ahead to 80p-84p. We repeatedly urged you to buy more, and average down, in the 60s and 70s and hope you took our advice. The stance is now VERY STRONG HOLD as we are through that 80p Limit Buying Price. But Hold on dear friends hold on as these shares will be pushing through 100p far sooner than folks think. The market is yet to appreciate how massive this demerger will be and also what other news Optibiotix itself will be serving up over the coming weeks. Hang on tight this is going to be exciting and soon! | incanus | |
23/3/2017 16:44 | Great day and I'll be very surprised if we're not blue again tomorrow. The chart looks absolutely amazing. And this before all the news that's expected! | parob | |
23/3/2017 16:23 | I'm late into this one but happy to hold! I hope it keeps on going up as April 7th approaches 😄 | moormoney | |
23/3/2017 16:15 | No complaints from me, Being of a certain age I need reminding lol | 18081 | |
23/3/2017 16:12 | someuwin, made me chuckle you having to remind everyone that it's the end of the (business) week tomorrow!....:) | plentymorefish | |
23/3/2017 16:06 | Could see 90p+ by the end of the week. i.e tomorrow. | someuwin | |
23/3/2017 16:03 | Higher highs and higher lows.... | shrewdmole | |
23/3/2017 15:50 | A discounted share offer would be ok as long as I can find enough money to fund the purchase.. | bobdown2 | |
23/3/2017 14:59 | Fun fact....Opti reached its 97p all time high at close on November 12th 2015. The market did not know or have a clue about skin at this time. In march 2016 we were informed opti would use its investors funds to acquire 73% of skin ip from Manchester university for £650k. (This cash was from Optis cash reserves specifically and only raised for the development of its plans for the development of the optiscreen, optibiotics and weight management divisions) Since this period we have been now notified of Optis intent to list this recent purchase as a company with its own focussed team and cash resources in the region of £5-15£m whilst retaining a majority holding on listing at a higher price than what was paid for the initial investment. An additional bonus and the creation of an entirely new company that has itself massive opportunities.Get shares or not opti owns %40 and we own opti.... still think we will get something though | riskybusiness1 | |
23/3/2017 14:42 | Whooooosh Sorry jj couldn't resist a wind up!! S | shrewdmole | |
23/3/2017 14:41 | eddiegoldstein - Whilst it's kind of you to ask for my thoughts on Angle, I rarely discuss or disclose my investments these days. I have given some of my reasons in a blog post back in January 2016:- Best of luck with all your investments though. | michaelmouse | |
23/3/2017 14:02 | No please ssssshhhhhhhh Let the share price do your talking This rocket type shyte is always a kiss of death! | judijudi | |
23/3/2017 13:49 | ok, all together .. | onedayrodders | |
23/3/2017 13:22 | No rockets needed I suspect. | rafboy | |
23/3/2017 13:22 | "HOUSTON...WE NO LONGER HAVE A PROBLEM" 10 9 8 7 .... | onedayrodders | |
23/3/2017 13:21 | 2 v 2 and smallest buys having to pay full ask...could be an exciting pm as they raise it to attract sellers. | shrewdmole | |
23/3/2017 13:18 | ODR I'm sure someuwin will post a picture of a rocket when the time is right!!! | parob | |
23/3/2017 13:17 | Many peeps will be well aware of OPTI's 10 bagging from IPO at 8p up to 80p in 18 months. SKIN many well perform just as dramatically. Like OPTI, it will float with a very small valuation because it too will not require much initial funding and so number of shares will be limited. Thus I anticipate big demand for the shares on listing and a multi-bagging performance over the rest of this year. Which will be fantastic for new SKIN holders AND fantastic for OPTI holders too. Buy OPTI. And Buy SKIN too - imo. | someuwin | |
23/3/2017 13:14 | Parob .. please include the mandatory words "rocket" and "moon" in those statements. thanks | onedayrodders | |
23/3/2017 13:13 | Sorry ... can you repeat that again elrico ;o) | onedayrodders | |
23/3/2017 13:01 | 1-1, 1%-1%, same either way. The quote I used was from TW. OPTI retain c40%, while 30% is used for the IPO. That is my understand after having it checked. I agree with Someuwin, so it is my last comment on the IPO, if only to save me from repeating the same mistake I did yesterday. :) | elrico | |
23/3/2017 13:00 | Agree SM. This is going to sound ramptastic, but this feels and looks like it's ready to take off!Could move quickly with any buying pressure... | parob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions